Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose LY2878735 safety, pharmacokinetics, pharmacodynamics, and SERT occupancy study in healthy volunteers
NL-OMON34068Active, not recruiting
- Sponsor
- Eli Lilly and Company
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of LY2878735 in Visceral pain and chronic pain, sponsored by Eli Lilly and Company. Primary endpoints: Safety and tolerability, Pharmacokinetics and 1 more. Started May 2010; status: active, not recruiting.
02
Drugs
LY2878735
03
Conditions
Visceral painchronic pain
Beyond the preview
Go deeper on NL-OMON34068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34068.